The PARP inhibitor olaparib induces significant killing of ATM deficient lymphoid tumour cells in vitro and in vivo.

Victoria Weston, Ceri Oldreive, Anna Skowronska, DG Oscier, Guy Pratt, MJ Dyer, G Smith, Judith Powell, Z Rudzki, Pamela Kearns, Paul Moss, Alexander Taylor, Tatjana Stankovic

Research output: Contribution to journalArticlepeer-review

217 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The PARP inhibitor olaparib induces significant killing of ATM deficient lymphoid tumour cells in vitro and in vivo.'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases